003017.SZ
大洋生物
SZSE · Basic Materials · C 制造业 · CN
CNY 22.48
+0.27%Year over year
Reported trailing growth
- Revenue
- +11.5%
- EBITDA
- —
- EBIT
- +24.2%
- EPS
- +34.0%
- Free cash flow
- -77.4%
- Operating cash flow
- +5.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -0.4%
- EBITDA
- +15.4%
- EBIT
- +23.0%
- Net income
- +7.3%
- EPS
- -4.0%
- Free cash flow
- +3.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026